Business

Salix Pharmaceuticals Culminates Year-Long Constipation Awareness Campaign with New Social Media and Digital Initiatives Empowering Patients to Discuss Their Symptoms with a Health Care Provider

Launching in December for Constipation Awareness Month, Initiatives Include Partnerships with Wel...

articleBausch Health Companies Inc.December 1, 20224/company/bausch-health-companies-inc/news/salix-pharmaceuticals-culminates-year-long-constipation-awareness-campaign-with-new-social-media-and-digital-initiatives-empowering-patients-to-discuss-their-symptoms-with-a-health-care-provider
Salix Pharmaceuticals Culminates Year-Long Constipation Awareness Campaign with New Social Media and Digital Initiatives Empowering Patients to Discuss Their Symptoms with a Health Care Provider

About this update from Bausch Health Companies Inc.

[{"type":"text","content":"Salix Pharmaceuticals Culminates Year-Long Constipation Awareness Campaign with New Social Media and Digital Initiatives Empowering Patients to Discuss Their Symptoms with a Health Care ProviderLaunching in December for Constipation Awareness Month, Initiatives Include Partnerships with Well-Known Lifestyle and Health Care Practitioner InfluencersCampaign Coincides with Salix's Continued Support of Advocacy Groups Building Innovative Patient Education Programs and Advancing Disease State Research in 2023LAVAL, QC / ACCESSWIRE / December 1, 2022 / Salix Pharmaceuticals (\"Salix\"), the gastroenterology business of Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (\"Bausch Health\"), today announced the launch of a series of social media and digital initiatives to raise awareness during Constipation Awareness Month in December. The initiatives will discuss constipation diseases, including opioid-induced constipation (OIC), irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). It is estimated that approximately up to 80% of patients receiving opioid medications for chronic pain experience OIC,1 30 million adults have CIC,2,3 and 3.4 million have IBS-C.2,3The initiatives launching this month culminate a year in which Salix invested in a multipronged educational campaign that included the publication of digital content reaching more than 240 million consumers with valuable information about the symptoms of OIC, IBS-C, and CIC and treatment options they can discuss with their health care providers.Constipation Awareness Month initiatives included partnerships with Johanna Grange, a lifestyle influencer who is sharing her perspectives about living with IBS-C with her 73,000 Instagram followers and in her blog, and Ethan Melillo, a pharmacist with more than 189,000 TikTok followers, who over the past year has been working with Salix to share a series of informative videos on TikTok discussing OIC and treatment options.\"As an industry leader in the gastroenterology space, Salix is continually identifying innovative ways to connect with the patient communities we serve,\" said Nicola Kayel, vice president, Gastroenterology Marketing, Salix. \"In 2022, in addition to continuing to work with social media influencers lending their voice to raise awareness of gastrointestinal (GI) diseases, Salix becam...

More updates from Bausch Health Companies Inc.